Metraipolis › archive › dc_f561b0bdffb7

Establishment and Validation of a Cell-Based Relative Potency Method for Respiratory Syncytial Virus mRNA Vaccine Drug Substance — Europe PMC PMID:42188774

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188774
DOI
10.3390/vaccines14050401
License (as archived)
solo-consultazione
Archived
2026-11-03T02:16:20.852Z
SHA-256 of the archived text
1bb4b863fd02e7d07a5546a8f8764d4c2aab787b408e5efed327838a29ae4c20
Stable URL of this page
https://metraipolis.com/documento/dc_f561b0bdffb7

How to cite

Establishment and Validation of a Cell-Based Relative Potency Method for Respiratory Syncytial Virus mRNA Vaccine Drug Substance — Europe PMC PMID:42188774 — Europe PMC (en), https://europepmc.org/article/MED/42188774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f561b0bdffb7 (Metraipolis archive dc_f561b0bdffb7, sha256 1bb4b863fd02e7d07a5546a8f8764d4c2aab787b408e5efed327838a29ae4c20)
BibTeX
@misc{dcf561b0bdffb7,
  title = {Establishment and Validation of a Cell-Based Relative Potency Method for Respiratory Syncytial Virus mRNA Vaccine Drug Substance — Europe PMC PMID:42188774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f561b0bdffb7; sha256 1bb4b863fd02e7d07a5546a8f8764d4c2aab787b408e5efed327838a29ae4c20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188774. Agents can read the archived copy with the MCP tool read_document.